These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 22230575)
1. Protein engineering for therapeutics, part B. Preface. Wittrup KD; Verdine GL Methods Enzymol; 2012; 503():xiii-xiv. PubMed ID: 22230575 [No Abstract] [Full Text] [Related]
2. Advancing protein therapeutics: current challenges in protein therapeutics -- CHI's Second Annual Conference. He M IDrugs; 2006 Mar; 9(3):177-8. PubMed ID: 16523380 [No Abstract] [Full Text] [Related]
3. Recombinant therapeutic proteins: production platforms and challenges. Dingermann T Biotechnol J; 2008 Jan; 3(1):90-7. PubMed ID: 18041103 [TBL] [Abstract][Full Text] [Related]
4. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Pardridge WM; Boado RJ Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573 [TBL] [Abstract][Full Text] [Related]
5. Advances in radioimmunotherapy in the age of molecular engineering and pretargeting. Sharkey RM; Goldenberg DM Cancer Invest; 2006 Feb; 24(1):82-97. PubMed ID: 16466997 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of therapeutic protein in vivo activities through glycoengineering. Elliott S; Lorenzini T; Asher S; Aoki K; Brankow D; Buck L; Busse L; Chang D; Fuller J; Grant J; Hernday N; Hokum M; Hu S; Knudten A; Levin N; Komorowski R; Martin F; Navarro R; Osslund T; Rogers G; Rogers N; Trail G; Egrie J Nat Biotechnol; 2003 Apr; 21(4):414-21. PubMed ID: 12612588 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of protein therapeutics. De Groot AS; Scott DW Trends Immunol; 2007 Nov; 28(11):482-90. PubMed ID: 17964218 [TBL] [Abstract][Full Text] [Related]
8. Integrating cell-level kinetic modeling into the design of engineered protein therapeutics. Rao BM; Lauffenburger DA; Wittrup KD Nat Biotechnol; 2005 Feb; 23(2):191-4. PubMed ID: 15696150 [TBL] [Abstract][Full Text] [Related]
9. Protein engineering for therapeutics, Part A. Preface. Wittrup KD; Verdine GL Methods Enzymol; 2012; 502():xiii-xiv. PubMed ID: 22208991 [No Abstract] [Full Text] [Related]